Connecticut Wealth Management LLC Sells 185 Shares of Agilent Technologies, Inc. (NYSE:A)

Connecticut Wealth Management LLC trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 6.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,613 shares of the medical research company’s stock after selling 185 shares during the quarter. Connecticut Wealth Management LLC’s holdings in Agilent Technologies were worth $363,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. Victory Capital Management Inc. lifted its position in Agilent Technologies by 939.8% during the third quarter. Victory Capital Management Inc. now owns 2,296,512 shares of the medical research company’s stock valued at $256,796,000 after acquiring an additional 2,075,649 shares during the last quarter. Nordea Investment Management AB increased its holdings in Agilent Technologies by 233.7% in the 4th quarter. Nordea Investment Management AB now owns 2,666,416 shares of the medical research company’s stock worth $370,552,000 after buying an additional 1,867,377 shares during the period. Meritage Group LP purchased a new stake in shares of Agilent Technologies in the 3rd quarter valued at $184,437,000. Wellington Management Group LLP increased its stake in shares of Agilent Technologies by 17.4% in the third quarter. Wellington Management Group LLP now owns 10,255,526 shares of the medical research company’s stock worth $1,146,773,000 after acquiring an additional 1,519,134 shares during the period. Finally, Van ECK Associates Corp raised its holdings in shares of Agilent Technologies by 120.8% during the third quarter. Van ECK Associates Corp now owns 2,596,227 shares of the medical research company’s stock worth $290,310,000 after purchasing an additional 1,420,430 shares during the last quarter.

Analysts Set New Price Targets

Several equities research analysts have commented on A shares. Oppenheimer upped their price objective on Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a research report on Tuesday, March 26th. Stifel Nicolaus upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $145.00 to $163.00 in a research report on Friday, April 5th. Barclays raised their target price on Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a research report on Wednesday, April 10th. UBS Group upped their price target on Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. Finally, Citigroup boosted their price objective on Agilent Technologies from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $141.29.

Agilent Technologies Trading Up 1.2 %

Shares of NYSE:A traded up $1.68 during trading on Monday, reaching $141.13. The stock had a trading volume of 512,977 shares, compared to its average volume of 1,517,077. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $151.58. The business has a fifty day moving average price of $142.07 and a 200-day moving average price of $131.79. The stock has a market cap of $41.36 billion, a P/E ratio of 33.20, a PEG ratio of 4.22 and a beta of 1.13. The company has a quick ratio of 2.04, a current ratio of 2.68 and a debt-to-equity ratio of 0.41.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.07. The firm had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. Agilent Technologies’s revenue was down 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.37 earnings per share. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.5 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were paid a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a dividend yield of 0.67%. The ex-dividend date was Monday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.38%.

Insider Transactions at Agilent Technologies

In other news, VP Rodney Gonsalves sold 4,828 shares of the stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $149.00, for a total transaction of $719,372.00. Following the transaction, the vice president now owns 21,329 shares of the company’s stock, valued at $3,178,021. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, VP Rodney Gonsalves sold 4,828 shares of the firm’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $149.00, for a total value of $719,372.00. Following the transaction, the vice president now directly owns 21,329 shares in the company, valued at approximately $3,178,021. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Michael R. Mcmullen sold 52,297 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $150.00, for a total value of $7,844,550.00. Following the transaction, the chief executive officer now owns 253,909 shares of the company’s stock, valued at $38,086,350. The disclosure for this sale can be found here. Over the last quarter, insiders sold 61,610 shares of company stock valued at $9,220,333.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.